Policy

Letters, Comments & Testimony
May 10, 2024
BIO submitted these comments in response to the United States Patent and Trademark Office’s May 10, 2024, Notice of Proposed Rulemaking regarding Terminal Disclaimer Practice to Obviate Nonstatutory Double Patenting.
May 15, 2024
On behalf of its member organizations, Biotechnology Innovation Organization (“BIO”) respectfully submits this Comment in response to the United States Patent and Trademark Office’s (the “Patent Office” or “PTO”) February 13, 2024 Request for Comments. See 89 FR 10043 (the “Guidance”). BIO is the…
May 9, 2024
BIO comments on a proposed rule to restrict planting of GE organisms on national wildlife refuge lands. 
Insurers and PBMs are implementing “co-pay accumulator” programs – an effort to prevent funds provided by manufacturer assistance programs from…
Adopting foreign price controls on innovative medicines would severely chill investment in new cures and therapies for diseases and jeopardize access…